SELL TO SCIENTISTS.

Research field

Gene Therapy

Gene therapy corrects genetic diseases by delivering functional copies of genes, editing faulty sequences, or silencing harmful gene expression using nucleic acid medicines and viral vectors. Adeno-Associated virus vectors have achieved durable therapeutic benefit in hemophilia, spinal muscular atrophy, and retinal dystrophies. CRISPR base editors make precise single-nucleotide changes without double-strand breaks, dramatically expanding the range of correctable mutations. mRNA lipid nanoparticle technology, validated at scale by COVID-19 vaccines, is being applied to metabolic and cardiovascular diseases. CAR-T cell therapies have transformed outcomes in certain blood cancers. Gene therapy is transitioning from rare disease niche to a platform for broad therapeutic application.

31,000 Researchers
$1.2M Avg funding
5 Subfields
5 Top institutions

Top institutions

University of Pennsylvania

Harvard Broad Institute

Nationwide Children's Hospital

UCL Great Ormond Street

Généthon France

Subfields

Viral Vector Gene Delivery Base Editing Prime Editing CAR-T Cell Therapy RNA Therapeutics

Key technologies

Adeno-Associated Virus Vectors

Lipid Nanoparticles

CRISPR Base Editors

Antisense Oligonucleotides

Lentiviral Vectors

Free to browse · subscribe to unlock the full dataset

See the full dataset.

Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.

Sign Up Free →
Get Started